Anastasios Zervas - Concepedia

Author

Anastasios Zervas

National and Kapodistrian University of Athens

Also Known As

A Zervas, A. ZERVAS, A. Zervas, Anastasios Zervas, Zervas, Anastasios

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Athens State University Laiko General Hospital of Athens Athens Medical Center University of Patras

About

Anastasios Zervas is an author at National and Kapodistrian University of Athens specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	748
2	Engineering	1	1	31
3	Health Sciences	1	1	67
4	Social Sciences	1	1	31
5	Behavioral Sciences	1	1	31

Anastasios Zervas

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group Aristotelis Bamias, Gerasimos Aravantinos, C. Deliveliotis, Journal of Clinical Oncology	2003	187
The prevalence of bcl-2, p53, and ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates Lydia Nakopoulou, Christina Vourlakou, Anastasios Zervas, Human Pathology UrologyGenitourinary CancerMalignant DiseaseMedicinePathology	1998	130
Nitric Oxide Synthase and Xanthine Oxidase Activities in the Spermatic Vein of Patients with Varicocele: A Potential Role for Nitric Oxide and Peroxynitrite in Sperm Dysfunction Dionisios Mitropoulos, George Deliconstantinos, Anastasios Zervas, The Journal of Urology	1996	103
Oral estramustine and oral etoposide for hormone-refractory prostate cancer Meletios Α. Dimopoulos, C Panopoulos, Christina Bamia, Urology OncologyMedicinePharmacotherapyProstatic DiseaseOral Estramustine	1997	80
Short‐ and long‐term complications of open radical prostatectomy according to the Clavien classification system Constantinos Constantinides, Stavros Ι. Tyritzis, Andreas Skolarikos, British Journal of Urology	2008	72
Symptomatic Benign Prostate Hyperplasia: Impact on Partners’ Quality of Life Dionisios Mitropoulos, Ιoannis Anastasiou, Constantina Giannopoulou, European Urology Family MedicineQuality Of LifeUrologySexual Well-beingBenign Prostatic Hyperplasia	2002	67
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group Meletios Α. Dimopoulos, C. Bakoyannis, Vassilis Georgoulias, Annals of Oncology UrologyGenitourinary CancerMedicineCancer TreatmentAdvanced Carcinoma	1999	67
Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: Comparison with dna ploidy L. Nakopoulou, C. Constantinides, J. Papandropoulos, Urology UrologyGenitourinary CancerMedicinePathologyDna Ploidy	1995	50
Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer. Lydia Nakopoulou, Anastasios Zervas, Hariklia Gakiopoulou-Givalou, PubMed	2001	50
Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications Ioanna Giannopoulou, Lydia Nakopoulou, Anastasios Zervas, Urological Research Urinary Bladder CancerPro-apoptotic Factors BaxUrologyPerineural InvasionGenitourinary Cancer	2002	47

Page 1